Novavax, COVID-19
Novavax Is Here for the COVID Fight: What to Know About the Vaccine
Novavax's protein-based shot is an option for COVID vaccination this season, joining refreshed formulas from Moderna and Pfizer.
For Canadians seeking a non-mRNA COVID vaccine, lack of Novavax shot is ‘unfair’
The federal government's decision to not provide Novavax's COVID-19 vaccine this respiratory virus season raises health equity concerns, experts and advocates say, as some Canadians look to the U.S. t
COVID-19 tests, variants and updated vaccines: Here’s what you need to know
The newest update to the COVID-19 vaccine reached pharmacies as infections in Indiana began to rise. Members of our audience had questions about the COVID-19 vaccine, tests and variants.
Canada not ordering Novavax protein-based COVID vaccine this year due to low demand
TORONTO — The Public Health Agency of Canada says it is not providing Novavax’s COVID-19 vaccine this respiratory virus season, citing lack of demand. It says the manufacturer requires a minimum order of its updated protein-based vaccine, called Nuvaxovid, which far exceeds the uptake by Canadians last year.
Canada won’t be ordering Novavax’s updated COVID-19 vaccine, cites low demand
The Public Health Agency of Canada says a very small portion of the doses ordered in 2023 were used and that its decision reflects efforts to limit vaccine wastage.
Make Room, mRNA: What to Know About the Novavax COVID Vaccine
In addition to Pfizer and Moderna's new formulas, Novavax's protein-based shot is an option for COVID vaccination this season.
Canadian government not ordering Novavax’s protein-based COVID-19 vaccine this year
TORONTO - The Public Health Agency of Canada says it is not providing Novavax's COVID-19 vaccine this respiratory virus season, citing low demand.
Is one COVID vaccine better than the others? An infectious disease doctor breaks it down
The FDA recently approved the updated mRNA Pfizer and Moderna boosters, as well as the updated Novavax COVID vaccine, to ...
Novavax cools after clarifying analyst report on COVID vaccine market
Novavax (NASDAQ:NVAX) shares fell ~3% in the premarket on Thursday after the company issued a clarification on an analyst ...
It’s time to roll up sleeves for new COVID, flu shots
“Right now is the best time” to get all the recommended fall vaccinations, said Dr. Mandy Cohen, director of the Centers for ...
Sonoma State Star12d
The new COVID-19 vaccine: To get or not to get?
On Aug. 22, the U.S. Food and Drug Administration announced the approval of a new Novavax COVID vaccine, as well as updated ...
Novavax: Lack Of Sustainable Revenue Growth Is A Problem
Novavax's financial position improved significantly with a $570 million cash infusion from Sanofi. Find out why I remain ...